Gain Therapeutics, Inc.GANXNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank83
3Y CAGR+61.9%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+61.9%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
4.2x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20246.73+99.1%
20233.38+71.7%
20221.97+24.3%
20211.59-92.6%
202021.45+110.3%
2019-208.45-202.0%
2018-69.02-